Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.

The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.

ARSENAL are looking ahead to what is expected to be a MASSIVE summer transfer window for the club! A new striker is top of ...

A single dad has shared online why his 3-year-old daughter is much smaller compared to other children her age. Diagnosed with hypopituitarism, a rare pituitary condition, Nova Rose was born ...

The extensive evidence supports the conclusion that the benefits vastly outweigh any minimal risks, positioning ProstaVive as ...

ABOUT When The Photocopier Runs Out Of Ink is a meme that gained momentum as individuals on music streaming sites realized a ...